China Biologic Nabs $315M In Upsized Follow-On Offering
China Biologic Products Inc. drew $315 million in an upsized stock offering Wednesday, as the U.S.-listed plasma-product maker targeted capital for potential deals or general corporate purposes and its private equity...To view the full article, register now.
Already a subscriber? Click here to view full article